Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment
Shahin Aghamiri, Sam Talaei, Afshin Abdi Ghavidel, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 56, pp. 101533-101533
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

DNA hydrogel-based gene editing and drug delivery systems
Fangli Mo, Kai Jiang, Di Zhao, et al.
Advanced Drug Delivery Reviews (2020) Vol. 168, pp. 79-98
Closed Access | Times Cited: 242
How can nanotechnology help to combat COVID-19? Opportunities and urgent need
Estefânia Vangelie Ramos Campos, Anderson do Espírito Santo Pereira, Jhones Luiz de Oliveira, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 210
Advantage of Nanotechnology-Based Genome Editing System and Its Application in Crop Improvement
Sunny Ahmar, Tahir Mahmood, Sajid Fiaz, et al.
Frontiers in Plant Science (2021) Vol. 12
Open Access | Times Cited: 112
Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis
Mesfin Dessale, Getachew Mengistu, Hylemariam Mihiretie Mengist
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3735-3749
Open Access | Times Cited: 109
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 72
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions
Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 61
Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development
Hamdoon A. Mohammed, Riaz Khan, Varsha Singh, et al.
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 60
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
Shanu Bhardwaj, Kavindra Kumar Kesari, Mahesh Rachamalla, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 207-221
Open Access | Times Cited: 74
Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications
Kristina Živojević, Minja Mladenović, Mila Djisalov, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 193-211
Open Access | Times Cited: 66
Liposome-based diagnostic and therapeutic applications for pancreatic cancer
Faisal Raza, Lauren Evans, Mahzad Motallebi, et al.
Acta Biomaterialia (2022) Vol. 157, pp. 1-23
Open Access | Times Cited: 54
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
Sajad Najafi, Shing Cheng Tan, Shahin Aghamiri, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112743-112743
Open Access | Times Cited: 43
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1257-1287
Open Access | Times Cited: 39
Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance
Hiva Kadkhoda, Pourya Gholizadeh, Hossein Samadi Kafil, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34692-e34692
Open Access | Times Cited: 9
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment
Asif Nawaz, Nur Aisya Affrina Mohamed Ariffin, Wong Tin Wui
Asian Journal of Pharmaceutical Sciences (2025), pp. 101041-101041
Open Access | Times Cited: 1
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Daniel J. Turnham, Nicholas Bullock, Manisha S. Dass, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2342-2342
Open Access | Times Cited: 62
Antimicrobial peptides as potential therapeutics for breast cancer
Shahin Aghamiri, Farshid Zandsalimi, Pourya Raee, et al.
Pharmacological Research (2021) Vol. 171, pp. 105777-105777
Closed Access | Times Cited: 47
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Paula Germino-Watnick, Malikiya Hinds, Anh‐Tuan Le, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1843-1843
Open Access | Times Cited: 35
CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review
Nirmal Chandra Barman, Md. Niuz Morshed Khan, Maidul Islam, et al.
Neurology and Therapy (2020) Vol. 9, Iss. 2, pp. 419-434
Open Access | Times Cited: 46
Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer
Epiphane K. Silli, Mengfei Li, Yuting Shao, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 192, pp. 13-24
Closed Access | Times Cited: 15
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
Neda Rostami, Mohammad Mahmoudi Gomari, Edris Choupani, et al.
Small Science (2024)
Open Access | Times Cited: 5
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants
Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
In Vitro Prostate Cancer Treatment via CRISPR‐Cas9 Gene Editing Facilitated by Polyethyleneimine‐Derived Graphene Quantum Dots
Bong Lee, Klara Gries, Alina Valimukhametova, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 48
Closed Access | Times Cited: 13
Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies
Dilpreet Singh
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 4
Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing
S. Sowmya, Dominic Augustine, Shazia Mushtaq, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy
Shahin Aghamiri, Sam Talaei, Soheil Roshanzamiri, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 6, pp. 753-766
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top